Antibody Drug Conjugates for Cancer Therapy
Antibody Drug Conjugates for Cancer Therapy Antibody Drug Conjugates for Cancer Therapy
Antibody doses are normalized to drug equivalenceTumor volume
Strategies to Control Stoichiometry of Cysteine-DirectedAntibody Drug Conjugation* * ** ** ** *Conventional ADCTHioMAb drug conjugate (TDC)Thiol reactive drugsare conjugated toreduced disulfidesEngineeredCysteine Thiol(A118C)2 420681Drugs / antibodyDrugs / antibody31
- Page 1 and 2: Antibody Drug Conjugates for Cancer
- Page 3: Target Screening- Large scale mRNA-
- Page 6 and 7: Naked antibodies are likely to be i
- Page 9 and 10: How many xenograft models should we
- Page 11 and 12: RelativeTenB2 expression in human p
- Page 13 and 14: Antibodies armed with auristatinsAN
- Page 15: MRP4 (multi drug resistance protein
- Page 18 and 19: Structure of the MUC16 antigen and
- Page 20 and 21: Endothelin B receptor: A target for
- Page 22 and 23: Melanocytes and EDNBR staining in n
- Page 24 and 25: Increased cell killing in vitro wit
- Page 26 and 27: ETBR Expression in Cell Lines versu
- Page 28 and 29: Efficacy/SafetyFour ways for armed
- Page 32 and 33: In Vivo Efficacy is Retained With T
- Page 34 and 35: Cumulative toxicity from long-lived
- Page 36: • GNE ADC Team- Susan Spencer- Ke
Strategies to Control Stoichiometry of Cysteine-Directed<strong>Antibody</strong> <strong>Drug</strong> Conjugation* * ** ** ** *Conventional ADCTHioMAb drug conjugate (TDC)Thiol reactive drugsare conjugated toreduced disulfidesEngineeredCysteine Thiol(A118C)2 420681<strong>Drug</strong>s / antibody<strong>Drug</strong>s / antibody31
Change language